A market model by GlobalData forecasts the peripheral vascular stent market to be worth $3bn by 2033. Abbott’s vascular business divisional vice president of global clinical affairs Jennifer ...

Abbott announced on Monday. This system represents the first drug-eluting resorbable scaffold with this indication, with balloon angioplasty alone as the standard of care for endovascular ...